Techno Medical Public Company Limited
Techno Medical Public Company Limited, together with its subsidiaries, engages in trading of medical supplies, tools, and equipment in Thailand. The company operates through three segments: Sales of Disposable Equipment and Supplies; Sales of Medical Equipment and Instrument; and Services Relating to Nursing Care. It also engages in the provision of nursing-care services; and wholesale trading of… Read more
Techno Medical Public Company Limited (TM) - Net Assets
Latest net assets as of September 2025: ฿444.10 Million THB
Based on the latest financial reports, Techno Medical Public Company Limited (TM) has net assets worth ฿444.10 Million THB as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (฿862.79 Million) and total liabilities (฿418.69 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ฿444.10 Million |
| % of Total Assets | 51.47% |
| Annual Growth Rate | 7.28% |
| 5-Year Change | -11.06% |
| 10-Year Change | 162.15% |
| Growth Volatility | 142.63 |
Techno Medical Public Company Limited - Net Assets Trend (2004–2024)
This chart illustrates how Techno Medical Public Company Limited's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Techno Medical Public Company Limited (2004–2024)
The table below shows the annual net assets of Techno Medical Public Company Limited from 2004 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | ฿420.14 Million | -8.95% |
| 2023-12-31 | ฿461.44 Million | -5.59% |
| 2022-12-31 | ฿488.76 Million | -3.47% |
| 2021-12-31 | ฿506.32 Million | +7.18% |
| 2020-12-31 | ฿472.39 Million | +5.80% |
| 2019-12-31 | ฿446.51 Million | +7.94% |
| 2018-12-31 | ฿413.68 Million | +5.97% |
| 2017-12-31 | ฿390.39 Million | +9.48% |
| 2016-12-31 | ฿356.57 Million | +122.49% |
| 2015-12-31 | ฿160.27 Million | +21.94% |
| 2014-12-31 | ฿131.43 Million | +35.74% |
| 2013-12-31 | ฿96.83 Million | +18.65% |
| 2012-12-31 | ฿81.61 Million | +569.69% |
| 2011-12-31 | ฿12.19 Million | +295.52% |
| 2010-12-31 | ฿3.08 Million | +1.55% |
| 2009-12-31 | ฿3.03 Million | -95.40% |
| 2008-12-31 | ฿65.93 Million | -46.99% |
| 2007-12-31 | ฿124.37 Million | -65.96% |
| 2006-12-31 | ฿365.33 Million | +64.27% |
| 2005-12-31 | ฿222.40 Million | +115.75% |
| 2004-12-31 | ฿103.08 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Techno Medical Public Company Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 661.6% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ฿23.48 Million | 6.18% |
| Common Stock | ฿154.00 Million | 40.54% |
| Other Comprehensive Income | ฿18.38 Million | 4.84% |
| Other Components | ฿184.03 Million | 48.44% |
| Total Equity | ฿379.90 Million | 100.00% |
Techno Medical Public Company Limited Competitors by Market Cap
The table below lists competitors of Techno Medical Public Company Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
DSS Inc
NYSE MKT:DSS
|
$2.95 Million |
|
LakeShore Biopharma Co., Ltd
NASDAQ:LSB
|
$2.95 Million |
|
Trillion Energy International Inc.
OTCQB:TRLEF
|
$2.96 Million |
|
IT Tech Packaging Inc
NYSE MKT:ITP
|
$2.96 Million |
|
Inocycle Technology Tbk PT
JK:INOV
|
$2.95 Million |
|
Ev Dynamics (Holdings) Limited
PINK:CHDHF
|
$2.95 Million |
|
Borneo Olah Sarana Sukses PT
JK:BOSS
|
$2.95 Million |
|
Gateway Real Estate AG
XETRA:GTY
|
$2.95 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Techno Medical Public Company Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 411,699,554 to 379,895,016, a change of -31,804,538 (-7.7%).
- Net loss of 21,640,575 reduced equity.
- Dividend payments of 10,163,963 reduced retained earnings.
- Other comprehensive income increased equity by 740,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ฿-21.64 Million | -5.7% |
| Dividends Paid | ฿10.16 Million | -2.68% |
| Other Comprehensive Income | ฿740.00K | +0.19% |
| Other Changes | ฿-740.00K | -0.19% |
| Total Change | ฿- | -7.73% |
Book Value vs Market Value Analysis
This analysis compares Techno Medical Public Company Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.62x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has increased from 0.48x to 0.62x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2012-12-31 | ฿1.61 | ฿0.77 | x |
| 2013-12-31 | ฿1.91 | ฿0.77 | x |
| 2014-12-31 | ฿2.60 | ฿0.77 | x |
| 2015-12-31 | ฿3.17 | ฿0.77 | x |
| 2016-12-31 | ฿1.51 | ฿0.77 | x |
| 2017-12-31 | ฿1.27 | ฿0.77 | x |
| 2018-12-31 | ฿1.34 | ฿0.77 | x |
| 2019-12-31 | ฿1.45 | ฿0.77 | x |
| 2020-12-31 | ฿1.45 | ฿0.77 | x |
| 2021-12-31 | ฿1.45 | ฿0.77 | x |
| 2022-12-31 | ฿1.40 | ฿0.77 | x |
| 2023-12-31 | ฿1.34 | ฿0.77 | x |
| 2024-12-31 | ฿1.23 | ฿0.77 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Techno Medical Public Company Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -5.70%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -2.98%
- • Asset Turnover: 0.80x
- • Equity Multiplier: 2.39x
- Recent ROE (-5.70%) is below the historical average (17.68%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2004 | 40.96% | 6.72% | 1.96x | 3.11x | ฿31.91 Million |
| 2005 | 20.33% | 4.60% | 1.49x | 2.97x | ฿22.97 Million |
| 2006 | 13.78% | 4.24% | 1.51x | 2.16x | ฿13.81 Million |
| 2011 | 74.72% | 0.62% | 1.34x | 89.31x | ฿7.89 Million |
| 2012 | 31.49% | 7.90% | 1.11x | 3.59x | ฿17.53 Million |
| 2013 | 20.88% | 5.58% | 1.06x | 3.52x | ฿10.53 Million |
| 2014 | 26.33% | 8.56% | 1.13x | 2.72x | ฿21.46 Million |
| 2015 | 17.99% | 5.64% | 0.98x | 3.26x | ฿12.81 Million |
| 2016 | 7.55% | 4.84% | 0.79x | 1.97x | ฿-8.75 Million |
| 2017 | 9.06% | 5.63% | 0.89x | 1.82x | ฿-3.67 Million |
| 2018 | 11.68% | 7.50% | 0.88x | 1.76x | ฿6.93 Million |
| 2019 | 13.64% | 8.88% | 0.88x | 1.75x | ฿16.27 Million |
| 2020 | 9.18% | 6.51% | 0.86x | 1.65x | ฿-3.68 Million |
| 2021 | 6.82% | 4.52% | 0.80x | 1.88x | ฿-14.22 Million |
| 2022 | 3.01% | 2.02% | 0.69x | 2.15x | ฿-30.17 Million |
| 2023 | -1.09% | -0.64% | 0.71x | 2.39x | ฿-45.66 Million |
| 2024 | -5.70% | -2.98% | 0.80x | 2.39x | ฿-59.63 Million |
Industry Comparison
This section compares Techno Medical Public Company Limited's net assets metrics with peer companies in the Medical Distribution industry.
Industry Context
- Industry: Medical Distribution
- Average net assets among peers: $54,991,435
- Average return on equity (ROE) among peers: 38.97%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Techno Medical Public Company Limited (TM) | ฿444.10 Million | 40.96% | 0.94x | $2.95 Million |
| E for L Aim Public Company Limited (EFORL) | $-104.57 Million | 0.00% | 0.00x | $13.47 Million |
| Healthlead Public Company Limited (HL) | $124.97 Million | 41.67% | 2.19x | $14.54 Million |
| SEI (SEI) | $28.36 Million | 62.98% | 8.85x | $3.29 Million |
| SaintMed Public Company Limited (SMD) | $135.64 Million | 40.21% | 2.49x | $11.69 Million |
| Winnergy Medical Public Company Limited (WINMED) | $90.56 Million | 49.99% | 2.66x | $3.06 Million |